Inaktiver Wert

Juniper Pharmaceuticals Inc Aktie

Aktien

Dauer

Zeitraum

Stil

Juniper Pharmaceuticals : Reports Second Quarter 2018 Financial and Operating Results	09.08.18
Dow Jones Industrial Average : Les valeurs à suivre à Wall Street	03.07.18
Juniper Pharmaceuticals : Signs Definitive Agreement to be Acquired by Catalent, Inc. for $11.50 Per Share in Cash	03.07.18
Juniper Pharmaceuticals : Reports First Quarter 2018 Financial and Operating Results	10.05.18
Juniper Pharmaceuticals : to Report First Quarter 2018 Results on May 10, 2018	01.05.18

Manager	Titel	Alter	Seit
Steven Fasman BRD	Director/Board Member	61	14.08.18

Aufsichtsräte	Titel	Alter	Seit
Steven Fasman BRD	Director/Board Member	61	14.08.18
James Geraghty CHM	Chairman	70	26.05.15

Sektor